CIK 0000812796
- Non-accelerated filer
- Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411505029
- Phone
- +1 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- 8-K Event Material agreement
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 8-K Event Material agreement
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Other events
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Executive or director change
- 8-K Event Other events
- 8-K Event Material agreement · Executive or director change
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Delisting notice
- 8-K Event Unregistered share sale · Other events
- 8-K Event Material agreement
Page 13 of 16 · 311 filings